基本信息
浏览量:158
职业迁徙
个人简介
Dr. Manoharan joined Alnylam in 2003. He was the former Executive Director of Medicinal Chemistry at Isis Pharmaceuticals, Inc., a leading biotechnology company focused on nucleic acid-based therapeutics where he had a12-year tenure. With a distinguished career as a world-leading nucleic acid and bioconjugate chemist, Mano is an author on over 130 publications and over 200 abstracts, as well as the inventor on over 115 issued U.S. patents. Prior to Isis Pharmaceuticals, he earned his Ph.D. in chemistry at the University of North Carolina-Chapel Hill and conducted post-doctoral work at Yale University and the University of Maryland.
研究兴趣
论文共 577 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
S. Engelbeen,Svetlana Pasteuning-Vuhman, Joke Boertje-van der Meulen,Rubina Parmar,Klaus Charissé,Laura Sepp‐Lorenzino,Muthiah Manoharan,Annemieke Aartsma‐Rus,M. van Putten
Nucleic Acid Therapeuticsno. 1 (2023): 26-34
引用3浏览0引用
3
0
Shubaash Anthiya,Süleyman Can Öztürk,Hamdullah Yanik,Ece Tavukcuoglu,Adem Şahin,Dhrubajyoti Datta,Klaus Charisse, David Moreira Álvarez, María Isabel Loza,Alfonso Calvo,Einar Sulheim, Simon Loevenich,
Sarah Engelbeen,Svetlana Pasteuning-Vuhman, Joke Boertje-van der Meulen,Rubina Parmar,Klaus Charisse,Laura Sepp-Lorenzino,Muthiah Manoharan,Annemieke Aartsma-Rus,Maaike van Putten
JOURNAL OF ORGANIC CHEMISTRYno. 21 (2023): 15168-15175
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn